Perth-based Resonance Health Ltd has appointed Dr Gary Pace as chairman. Dr Pace is currently chairman and CEO of QRxPharma Pty Ltd and a director of several companies, including Queensland-based Peplin Ltd. From 1995 to 2001, Dr Pace was president and CEO of RTP Pharma and from 2000 to 2002 he was chairman and CEO of Waratah Pharmaceuticals Inc., a spin-off company of RTP Pharma.